Papers
2
Total Citations
41
H-Index
2
About
Amr Emara is a urologic surgeon and researcher whose work focuses on advancing minimally invasive treatments for kidney and prostate cancers. His research critically compares emerging technologies against established surgical standards, aiming to improve patient outcomes while reducing morbidity. His most influential work, "Robot‐assisted partial nephrectomy vs laparoscopic cryoablation for the small renal mass," with 37 citations, redefined the debate over the "gold standard" for treating small renal tumors by directly comparing the safety and peri-operative outcomes of these two minimally invasive approaches. More recently, Emara has tackled the challenging problem of radiorecurrent prostate cancer. His 2026 study, "Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer," compares salvage focal therapy (sFT) with salvage radical prostatectomy (sRP), suggesting that sFT may offer effective cancer control with fewer side effects for patients with localized recurrences after radiotherapy. This work addresses a critical unmet need for men with poor survival prospects following initial treatment failure. Through these comparative effectiveness studies, Emara is helping to shape clinical decision-making, offering patients less invasive options without compromising oncologic control.
Research Focus
Key Achievements
Top Papers
- 1
- 2